文献速递老年综合评估认知障碍与谵妄老年慢病共病管理

新冠疫情期间共病老年人认知加速下降

Cognitive Decline Before and During COVID-19 Pandemic Among Older People With Multimorbidity: A Longitudinal Study.
PubMed 文献 · J Am Med Dir Assoc · 2023-01-13

基于美国健康与退休研究(HRS)9304名≥50岁认知健康老年人、2016至2021年的5年队列,将2016至2019年设为对照期、2019至2021年设为疫情期。结果显示,疫情期间共病老年人整体认知下降加速(0.08个标准差,95%CI 0.03至0.13,P=.003),痴呆发病风险升高(风险比1.66,95%CI 1.05至2.61,P=.029);对照期未见显著差异。

要点

  • 疫情期间共病老年人整体认知下降加速0.08个标准差(95%CI 0.03至0.13,P=.003)。
  • 疫情期间共病老年人痴呆发病风险比为1.66(95%CI 1.05至2.61,P=.029)。
  • 对照期共病与无共病者认知下降无显著差异。

核心结论

  • 新冠疫情期间,共病老年人整体认知下降加速且痴呆发病风险升高,而疫情前认知下降速率未见明显差异。
  • 作者认为,针对共病脆弱老年人的干预措施可能对帮助其应对疫情期间的神经认知挑战具有重要意义。

研究设计与样本

  • 5年队列研究,调查年份为2016年至2021年,以2016至2019年为对照期、2019至2021年为疫情期。
  • 共纳入美国健康与退休研究(HRS)中9304名年龄≥50岁、认知健康的老年人,其中3649名(39.2%)为男性,平均年龄65.8±10.8岁。
  • 共病定义为同时存在2种及以上慢性病;整体认知z评分基于记忆(即时与延迟词语回忆测试)和执行功能(倒数与连续减7测试)计算;痴呆发病采用医生报告诊断或基于认知总结评分的替代方法定义。
  • 采用线性混合模型评估纵向变化,采用改良泊松回归模型分析痴呆发病风险。

主要发现

  • 共病组(n=4375)相比无共病组(n=1818),疫情期间整体认知下降加速0.08个标准差(95%CI 0.03至0.13,P=.003)。
  • 共病组相比无共病组,疫情期间痴呆发病风险比为1.66(95%CI 1.05至2.61,P=.029)。
  • 进一步调整社会人口学特征及疫情前认知测量后,上述差异依然明显。
  • 对照期共病组与无共病组的认知下降未见显著差异。

关键数值与推荐

  • 共病定义为同时存在2种及以上慢性病。
  • 整体认知z评分采用即时与延迟词语回忆测试以及倒数与连续减7测试计算。
  • 痴呆发病定义为医生报告诊断或基于认知总结评分的替代方法。

临床怎么用

  • 作者认为,针对共病脆弱老年人的干预措施可能对帮助其应对疫情期间的神经认知挑战具有重要意义。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether older people living with multimorbidity would suffer an accelerated decline in cognition during the COVID-19 pandemic, compared with prepandemic data. DESIGN: A 5-year cohort conducting surveys from year 2016 to 2021, with 2016 to 2019 as the control period and 2019 to 2021 the pandemic period. SETTING AND PARTICIPANTS: In total, 9304 cognitively healthy older participants age ≥50 years were included from the Health and Retirement Study (HRS). METHODS: Multimorbidity was defined as the concurrent presence of 2 or more chronic diseases. A global cognition z score was calculated using memory (immediate and delayed word recall tests) and executive function (counting backwards and the serial sevens tests). Incident dementia was defined using either the reported physician diagnosis or an alternative approach based on cognition summary score. Linear mixed models were used to assess longitudinal changes, while modified Poisson regression models were used to analyze the risk of incident dementia. RESULTS: Of the 9304 participants included, 3649 (39.2%) were men, with a mean age of 65.8 ± 10.8 years. Participants with multimorbidity (n = 4375) suffered accelerated declines of 0.08 standard deviation (95% confidence interval 0.03, 0.13, P = .003) in global cognition and an elevated dementia risk (risk ratio 1.66, 95% confidence 1.05 to 2.61, P = .029), compared with individuals without morbidity (n = 1818) during the pandemic period. After further adjusting sociodemographic characteristics and prepandemic cognitive measurements, these differences remained evident. In contrast, no significant differences in cognitive declines were observed during the control period. CONCLUSIONS AND IMPLICATIONS: During the COVID-19 pandemic, older people with multimorbidity suffered an accelerated decline in cognition and elevated incident dementia risk, while no evident differences in cognitive decline rates were observed before the pandemic. Measures targeting vulnerable older people with multimorbidity could be significant for assisting these individuals to tackle neurocognitive challenges during the pandemic.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Li C, Hua R, Gao D, et al. Cognitive Decline Before and During COVID-19 Pandemic Among Older People With Multimorbidity: A Longitudinal Study. J Am Med Dir Assoc. 2023. PMID: 36774966. doi:10.1016/j.jamda.2023.01.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。